PALATIN TECHNOLOGIES, INC. Investment Income, Net
PALATIN TECHNOLOGIES, INC. (PTN) reported Investment Income, Net of $149.28 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2026-05-13
- PALATIN TECHNOLOGIES, INC. investment income, net for the quarter ending 2026-03-31 was $149.28K, a 374.61% increase year-over-year.
- PALATIN TECHNOLOGIES, INC. investment income, net for the quarter ending 2025-12-31 was $65.19K, a 124.44% increase year-over-year.
- PALATIN TECHNOLOGIES, INC. investment income, net for the quarter ending 2025-09-30 was $18.48K, a 76.48% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. investment income, net for the quarter ending 2025-06-30 was $28.59K, a 72.48% decline year-over-year.
- PALATIN TECHNOLOGIES, INC. investment income, net for fiscal 2025 was $167.66K, a 55.51% decline from fiscal 2024.
- PALATIN TECHNOLOGIES, INC. investment income, net for fiscal 2024 was $376.84K, a 45.54% decline from fiscal 2023.
- PALATIN TECHNOLOGIES, INC. investment income, net for fiscal 2023 was $691.98K, a 2209.45% increase from fiscal 2022.
- PALATIN TECHNOLOGIES, INC. investment income, net for fiscal 2022 was $29.96K, a 27.11% increase from fiscal 2021.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month | Investment Income, Net 12 month |
|---|---|---|---|---|
| 2026-03-31 | $149.28K 10-Q · filed 2026-05-13 | $214.46K derived: sum of 2 quarters · filed 2026-05-13 | $232.94K 10-Q · filed 2026-05-13 | $261.54K derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-12-31 | $65.19K 10-Q · filed 2026-02-17 | $83.67K 10-Q · filed 2026-02-17 | $112.26K derived: sum of 3 quarters · filed 2026-02-17 | $143.71K derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-09-30 | $18.48K 10-Q · filed 2025-11-14 | $47.08K derived: sum of 2 quarters · filed 2025-11-14 | $78.53K derived: sum of 3 quarters · filed 2026-05-13 | $107.57K derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-06-30 | $28.59K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $60.05K derived: sum of 2 quarters · filed 2026-05-13 | $89.09K derived: sum of 3 quarters · filed 2026-05-13 | $167.66K 10-K · filed 2025-09-23 |
| 2025-03-31 | $31.45K 10-Q · filed 2026-05-13 | $60.50K derived: sum of 2 quarters · filed 2026-05-13 | $139.07K 10-Q · filed 2026-05-13 | $242.99K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $29.04K 10-Q · filed 2026-02-17 | $107.62K 10-Q · filed 2026-02-17 | $211.53K derived: sum of 3 quarters · filed 2026-02-17 | $350.81K derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-09-30 | $78.58K 10-Q · filed 2025-11-14 | $182.49K derived: sum of 2 quarters · filed 2025-11-14 | $321.76K derived: sum of 3 quarters · filed 2025-11-14 | $383.79K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $103.91K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $243.19K derived: sum of 2 quarters · filed 2025-09-23 | $305.21K derived: sum of 3 quarters · filed 2025-09-23 | $376.84K 10-K · filed 2025-09-23 |
| 2024-03-31 | $139.27K 10-Q · filed 2025-05-14 | $201.30K derived: sum of 2 quarters · filed 2025-05-14 | $272.93K 10-Q · filed 2025-05-14 | $455.90K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $62.03K 10-Q · filed 2025-02-13 | $133.66K 10-Q · filed 2025-02-13 | $316.63K derived: sum of 3 quarters · filed 2025-02-13 | $550.67K derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-09-30 | $71.63K 10-Q · filed 2024-11-14 | $254.60K derived: sum of 2 quarters · filed 2024-11-14 | $488.65K derived: sum of 3 quarters · filed 2024-11-14 | $675.12K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $182.97K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-30 | $417.02K derived: sum of 2 quarters · filed 2024-09-30 | $603.49K derived: sum of 3 quarters · filed 2024-09-30 | $691.98K 10-K · filed 2024-09-30 |
| 2023-03-31 | $234.04K 10-Q · filed 2024-05-15 | $420.52K derived: sum of 2 quarters · filed 2024-05-15 | $509.01K 10-Q · filed 2024-05-15 | $534.87K derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $186.47K 10-Q · filed 2024-02-14 | $274.96K 10-Q · filed 2024-02-14 | $300.82K derived: sum of 3 quarters · filed 2024-02-14 | $301.95K derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-09-30 | $88.49K 10-Q · filed 2023-11-14 | $114.35K derived: sum of 2 quarters · filed 2023-11-14 | $115.48K derived: sum of 3 quarters · filed 2023-11-14 | $117.04K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $25.86K derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-28 | $26.99K derived: sum of 2 quarters · filed 2023-09-28 | $28.55K derived: sum of 3 quarters · filed 2023-09-28 | $29.96K 10-K · filed 2023-09-28 |
| 2022-03-31 | $1.13K 10-Q · filed 2023-05-15 | $2.69K derived: sum of 2 quarters · filed 2023-05-15 | $4.10K 10-Q · filed 2023-05-15 | |
| 2021-12-31 | $1.56K 10-Q · filed 2023-02-14 | $2.97K 10-Q · filed 2023-02-14 | ||
| 2021-09-30 | $1.41K 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | $23.57K 10-K · filed 2022-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |